Thursday, June 5, 2025
HomeTagsSanofi

Sanofi

Sanofi Acquires Blueprint Medicines to Boost Immunology Pipeline

Sanofi announced a definitive agreement to acquire Blueprint Medicines Corporation, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and other KIT-driven diseases. This...

Sanofi completes acquisition of Dren Bio’s DR-0201

Sanofi announced the successful completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, a privately held, clinical-stage biopharmaceutical...

Sanofi Launches Phase 3 for PCV21, Expands SK Bioscience Partnership

Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and...

Vir and Sanofi Partner for T-Cell Engager License

Vir Biotechnology, Inc, announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and...

Medidata and Sanofi Vaccines expand collaboration to improve patient-centricity and clinical trial efficiency

Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions for the life sciences industry, and Sanofi Vaccines are leveraging Medidata eCOA to We...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics